Last reviewed · How we verify

NCT04661423: MONIREA

Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era

Completed NA Last updated 1 May 2025
What this trial tests

NA trial testing Remote Automated Monitoring System in Post ICU Rehabilitation in 60 participants. Completed in 2 March 2025.

Timeline
2 September 2021
Primary endpoint
2 March 2025
2 March 2025

Quick facts

Lead sponsorIHU Strasbourg
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment60
Start date2 September 2021
Primary completion2 March 2025
Estimated completion2 March 2025
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

IHU Strasbourg — full company profile →

Who can join

18 and older, any sex, with Post ICU Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this clinical study, the investigators will compare vital parameters measurements obtained using continuous data from reference monitors and continuous wireless MultiSense® monitoring patch in 60 post-ICU (Intensive Care Unit) patients and over 7 days.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Remote Automated Monitoring System

Trials testing the same drug.

Other IHU Strasbourg trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04661423.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing